AdisInsight: Early Adopter Offer

© SpringerSecure institutional access for 2015 and                  receive the rest of 2014 gratis;                                a saving of 25%! Act now!

                     **Offer valid until 9/30/14**

Give the AdisInsight database advantage! 

Providing access to the AdisInsight Database enables your researchers to research drugs in development worldwide, follow the progress of clinical trials, and ​keep up to date with the latest drug safety news. A must have tool for any medical, pharmacy, psychology, clinical chemistry programs, etc.

Four Powerful Databases,

One Integrated Platform.

Content Includes:

AdisInsight – Drugs: tracks & evaluates drug development worldwide (click for info)

At a Glance:

  • Collection of drug profiles authored by Adis
  • Consolidates information from around the world
  • Scientific focus – Phase, Properties, Pharmacokinetics, Pharmacodynamics, Structure, Clinical Trials
  • Commercially relevant – Brand names, Agreements, Probability of approval, Revenue forecasts
  • Drug development history table illustrates milestones met over time
  • Summaries of company deals
  • Covers all therapeutic areas and indications
  • Updated daily


  • Identify, monitor, and analyze the progress of R&D programs
  • Evaluate compounds and assess strengths and weaknesses
  • Estimate commercial potential of drugs and indications
  • Assess key scientific data for emerging technologies and drug classes
  • Review development success/failure rates
  • Evaluate R&D efficiency (time to clinical development/market)
  • Identify unmet needs or new marketing opportunities

AdisInsight – Trials: monitors global clinical trials and connects presented trial results (click for info)

At a Glance:

  • Collection of trial profiles authored by Adis
  • Consolidates information from around the world
  • Links to AdisInsight –Drugs provide complete picture of trials supporting drug development
  • Study details added as soon as they are announced and updated as progress is reported
  • Published and presented trial results summarized and connected to the clinical trial
  • Study centers and investigators captured comprehensively
  • Trial history table documents trial progress over time
  • Includes phase 0, I, II, III, and IV clinical trials
  • Covers all therapeutic areas and indications
  • Updated daily


  • Monitor the progress of clinical trials worldwide
  • Assess the body of evidence resulting from a trial by analyzing presented study results
  • Evaluate strengths and weaknesses of new treatments from trial endpoints and outcomes
  • Identify Key Opinion Leaders and study centers with experience in a specific area
  • Benchmark trials to determine trends in trial design to develop studies that show benefit
  • Map the clinical trials supporting development of drugs profiled in AdisInsight - Drugs

AdisInsight – Safety: keeps one informed of published adverse drug reaction case reports, drug safety studies, and regulatory news (click for info)

At a Glance:

  • Narrative summaries of adverse event case reports published in the literature authored by Adis
  • Case report summaries comply with Council for International Organizations of Medical Sciences (CIOMS II) guidelines for Periodic Safety Update Reports (PSURs)
  • Full reference information for the original publication
  • Serious, overdose, interaction and first published cases identified
  • WHO contextual adverse event data included for first reports
  • Important drug safety studies and regulatory news
  • Updated daily


  • Identify key studies focusing on adverse drug reactions
  • Identify previous reports of specific adverse drug reactions
  • Stay up-to-date with news of studies, regulatory developments and drug safety
  • Identify drug safety signals from timely, accurate information
  • Stay up to date with what’s new from regulatory agencies

AdisInsight – Deals: advises of agreements between organizations involved in drug development (click for info)

At a Glance:

  • Brief summaries of company agreements worldwide authored by Adis
  • Includes acquisitions, agreements, equity investment, joint venture, licensing, merger and purchase agreements
  • Precise searching by fielded categories including drug, indication, and organizations involved
  • Deal value and terms provided where available
  • Updated daily


  • Understand changes in the drug development landscape
  • Determine comparable deal value and terms by bench-marking completed deals
  • Identify potential suitors to acquire new treatments in early development

Why AdisInsight? Click For Features & Benefits...

Value of AdisInsight to Researchers & Faculty

AdisInsight content is curated and written by scientists who review and assess data across all available sources and summarize the relevant points in expert summaries, allowing your researchers to cut out the noise and get straight to the information that matters most to their research.

They can use the database to:

  • Research drugs in development worldwide
  • Follow the progress of clinical trials
  • Keep up to date with the latest drug safety news

Value of AdisInsight to Libraries & Librarians

Through a subscription to AdisInsight, you can provide users within your institution with a wealth of independent and timely, drug-related content to support their research and decision-making.

The new platform will link up to the SpringerLink content platform, meaning that users can use a single log-in and they will be able to use the database in much the same way as they already access existing journal and book content, via intuitive and easy to use search and browse functionalities. In addition, you will be able to access usage statistics and manage your subscription through a familiar interface.

With AdisInsight you can access and much of the content as you need, with content packages and purchase models built around your specific requirements. 

Unique Features and Benefits

AdisInsight offers comprehensive tools to support analysis of the data.

  • Scientific content authored by Adis experts distill complex information from many disparate sources into concise summary statements
  • Up to date content you can rely on harvested daily from public sources using the latest technology and curated manually by Adis expert editors
  • Integrated searching across all four content sets presents all the information about drugs, trials, safety, and deals from a single search
  • Simple search combined with powerful search results filters provide an intuitive interface for users
  • Detailed query builder allows power users to construct complicated searches to locate precisely what they are looking for
  • Connectivity to Springer provides seamless access to AdisInsight for user of other Springer content 

Special Offer Details

As an introductory promotion (until September 30th), North American* Academic & Government libraries have the ability to license the database for 2015 while receiving complimentary access to the remainder of 2014. A 25% discount on the current calendar year. 

Act now and provide content that delivers results!

*offer exclusive to United States & Canada Academic & Gov't Libraries

Contact Your Springer Licensing Manager

With flexible licensing options and a user-friendly interface, the AdisInsight Database is a wise investment for academic and government libraries seeking to deliver critical content to 21st century users. Ask your Springer Licensing Manager for more information on pricing and your gratis access. Or you can submit your interest by clicking here.

eMail us with any questions: /